Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 10.473\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a) CCc1nn2c(=O)cc(COC(=O)c3ccc(SC)cc3OC)nc2s1
b) O=[N+]([O-])c1cc2c(cc1/C=N/NS(=O)(=O)c1ccc(Br)cc1)OCO2
c) CC1CCN(CCC(=O)Nc2nccs2)CC1
Answer: a. CCc1nn2c(=O)cc(COC(=O)c3ccc(SC)cc3OC)nc2s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCc1nn2c(=O)cc(COC(=O)c3ccc(SC)cc3OC)nc2s1
CCc1nn2c(=O)cc(COC(=O)c3ccc(SC)cc3OC)nc2s1
(2-ethyl-5-oxo-[1,3,4]thiadiazolo[3,2-a]pyrimidin-7-yl)methyl 2-methoxy-4-methylsulfanylbenzoate